Company Summaries: 𝐀𝐛𝐨𝐮𝐭 𝐀𝐁𝐗-𝐂𝐑𝐎 ABX-CRO is specialised in the field of pre-clinical and clinical contract ...

LIGAND-AI is a flagship project of the Target 2035 initiative, funded by the Innovative Health Initiative, a public-private partnership (PPP) between the European Union and the European life science ...

The company's expansion in the biological assay space aided by the data platform SAN FRANCISCO and KYIV, Ukraine, June 10, 2021 /PRNewswire/ -- Enamine, a leading provider of R&D Services as well as ...

Access to Enamine's novel compounds will allow Reaxys users to cut development times and costs by up to 90% London, United Kingdom--(Newsfile Corp. - December 3, 2024) - Elsevier, a global leader in ...

KYIV, Ukraine & SANKT AUGUSTIN, Germany--(BUSINESS WIRE)--The two leading experts in the exploration of ultra-large make-on-demand chemical spaces join forces to spark a new era of drug discovery.

Open-science research initiative, COVID Moonshot and the AI-driven Structure-enabled Antiviral Platform (ASAP) consortium, delivered a promising pre-clinical candidate 2,000 new compounds generated ...

Metrion Biosciences Limited (“Metrion”), the specialist ion channel and cardiac safety screening contract research organization (CRO) and drug discovery company, and Enamine Ltd (“Enamine”), the ...

Orogen Therapeutics, Inc., a private drug discovery company utilizing its proprietary, AI-enabled DNA encoded library (DEL) technology to identify novel chemical matter against medically and ...

Enamine Ltd., a provider of drug discovery services empowered with the world’s largest collections of building blocks, fragments, and screening compounds, gave an update of its long-standing research ...

Enamine Ltd., a leading chemical research organization and producer of the world’s largest collections of novel building blocks (150,000) and screening compound libraries (2,400,000), and BioSolveIT ...